2019 Endocrine society measures set for older adults with type 2 diabetes who are at risk for hypoglycemia: Performance measures for eligible clinicians developed by the endocrine society

James L. Rosenzweig*, Paul R. Conlin, Jasmine D. Gonzalvo, Stephanie B. Kutler, Nisa M. Maruthur, Penelope Solis, Sandeep Vijan, Amisha Wallia, Robin Fein Wright

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

Context: Hypoglycemia in the outpatient setting has a significant financial impact on the health care system and negative impact on a person's quality of life. Primary care physicians must address a multitude of issues in a visit with a person with type 2 diabetes mellitus (T2DM), often leaving little time to ask about hypoglycemia. Objective: To develop quality measures that focus on outpatient hypoglycemia episodes for patients 65 and older with T2DM, which facilitate a clinician's ability to identify opportunities to improve the quality of care and reduce hypoglycemic episodes. Participants and Process: A technical expert panel established by the Endocrine Society in March 2019, which includes endocrinologists, primary care physicians, a diabetes care and education specialist/pharmacist, and a patient, developed 3 outpatient hypoglycemia quality measures. The measure set is intended to improve quality of care for patients with T2DM who are at greatest risk for hypoglycemia. The measures were available for public comment in July 2019. A fourth measure on shared decision-making was removed from the final measure set based on public feedback. Conclusion: A lack of outpatient hypoglycemia measures focusing on older adults with T2DM is a barrier to improving care of people with diabetes and reducing hypoglycemic episodes. This paper provides measure specifications for 3 measures that may be used to focus quality improvement efforts on patients at greatest risk for hypoglycemia.

Original languageEnglish (US)
Pages (from-to)969-990
Number of pages22
JournalJournal of clinical endocrinology and metabolism
Volume105
Issue number4
DOIs
StatePublished - Apr 1 2020

Funding

The Hypoglycemia Prevention Initiative and all related activities are supported by Abbott Diabetes Care Inc., Lilly USA, LLC, Merck & Co., Inc., Novo Nordisk Inc., and Sanofi.

Keywords

  • Diabetes
  • Diabetes medications
  • Hypoglycemia
  • Older adults
  • Performance measures
  • Quality improvement
  • Type 2 diabetes

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Fingerprint

Dive into the research topics of '2019 Endocrine society measures set for older adults with type 2 diabetes who are at risk for hypoglycemia: Performance measures for eligible clinicians developed by the endocrine society'. Together they form a unique fingerprint.

Cite this